Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Youssef Razouqi"'
Autor:
Hager Elnadi, Ahmad I. Al-Mustapha, Ismail A. Odetokun, AbdulAzeez Adeyemi Anjorin, Rasha Mosbah, Folorunso O. Fasina, Youssef Razouqi, Kwame Sherrif Awiagah, Jean Baptiste Nyandwi, Zuhal E. Mhgoob, George Gachara, Mohamed Farah Yusuf Mohamud, Bamu F. Damaris, Aala Mohamed Osman Maisara, Mona Radwan
Publikováno v:
COVID, Vol 3, Iss 11, Pp 1663-1676 (2023)
The impact of Post COVID-19 Condition (PCC) is ongoing despite the declaration that the 2019 COVID-19 pandemic has ended. In this study, we explore the prevalence of PCC among healthcare workers (HCWs) in four African Countries and its influence on t
Externí odkaz:
https://doaj.org/article/c9a9ddde49f049eea1a6be131fd49002
Autor:
AbdulAzeez A Anjorin, Ismail A Odetokun, Ajibola I Abioye, Hager Elnadi, Mfon Valencia Umoren, Bamu F Damaris, Joseph Eyedo, Haruna I Umar, Jean B Nyandwi, Mena M Abdalla, Sodiq O Tijani, Kwame S Awiagah, Gbolahan A Idowu, Sifeuh N Achille Fabrice, Aala M O Maisara, Youssef Razouqi, Zuhal E Mhgoob, Salim Parker, Osaretin E Asowata, Ismail O Adesanya, Maureen A Obara, Shameem Jaumdally, Gatera F Kitema, Taofik A Okuneye, Kennedy M Mbanzulu, Hajj Daitoni, Ezekiel F Hallie, Rasha Mosbah, Folorunso O Fasina
Publikováno v:
PLoS ONE, Vol 16, Iss 12, p e0260575 (2021)
The economic and humanistic impact of COVID-19 pandemic is enormous globally. No definitive treatment exists, hence accelerated development and approval of COVID-19 vaccines, offers a unique opportunity for COVID-19 prevention and control. Vaccine he
Externí odkaz:
https://doaj.org/article/92897729c759483992b063f6dd24c31e
Autor:
AbdulAzeez Adeyemi Anjorin, Ismail A. Odetokun, Jean Baptiste Nyandwi, Hager Elnadi, Kwame Sherrif Awiagah, Joseph Eyedo, Ajibola Ibraheem Abioye, George Gachara, Aala MohmedOsman Maisara, Youssef Razouqi, Mohamed Farah Yusuf Mohamud, Zuhal Ebrahim Mhgoob, Tunde Ajayi, Lazare Ntirenganya, Morounke Saibu, Babatunde Lawal Salako, Nusirat Elelu, Kikelomo Ololade Wright, Folorunso O. Fasina, Rasha Mosbah
Publikováno v:
Vaccines, Vol 10, Iss 4, p 546 (2022)
Local, national, and international health agencies have advocated multi-pronged public health strategies to limit infections and prevent deaths. The availability of safe and effective vaccines is critical in the control of a pandemic. Several adverse
Externí odkaz:
https://doaj.org/article/26852dd60663427683973152094ac3f3
Autor:
AbdulAzeez Anjorin, Ismail Odetokun, Jean Nyandwi, Hager Elnadi, Kwame Awiagah, Joseph Eyedo, Ajibola Abioye, George Gachara, Aala Maisara, Youssef Razouqi, Yusuf Mohamud Mohamed, Zuhal Mhgoob, Tunde Ajayi, Lazare Ntirenganya, Morounke Saibu, Babatunde Salako, Nusirat Elelu, Kikelomo Wright, Folorunsho Fasina, Rasha Mosbah
Background: The death toll and economic disaster caused by SARS-CoV-2/ COVID-19 is still on the rise globally and in Africa with a case fatality ratio (CFR), 2.58 from 220,958 deaths out of 8,556,890 cases recorded across the continent as of 14th Nov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f215b775598bbf8f22fd2396c36203b
https://doi.org/10.14293/111.000/000024.v1
https://doi.org/10.14293/111.000/000024.v1
Autor:
Gbolahan Idowu, Sodiq Olawale Tijani, Osaretin E. Asowata, Taofik A. Okuneye, Rasha A Mosbah, Maureen A. Obara, Bamu Fufor Damaris, Haruna Isiyaku Umar, Hager Elnadi, Kennedy Makola Mbanzulu, Ismail Olayinka Adesanya, Jean Baptiste Nyandwi, Hajj Daitoni, Youssef Razouqi, Kwame Sherrif Awiagah, Ismail Ayoade Odetokun, Mena M. Abdalla, Folorunso Oludayo Fasina, Ezekiel. F. Hallie, Joseph Eyedo, Aala MohmedOsman Maisara, Zuhal E. Mhgoob, Gatera F. Kitema, AbdulAzeez A. Anjorin, Salim Parker, Mfon Valencia Umoren, Ajibola I Abioye, Sifeuh Noussi Achille Fabrice, Shameem Z. Jaumdally
Publikováno v:
PLoS ONE, Vol 16, Iss 12, p e0260575 (2021)
PLoS ONE
PLoS ONE
The economic and humanistic impact of COVID-19 pandemic is enormous globally. No definitive treatment exists, hence accelerated development and approval of COVID-19 vaccines, offers a unique opportunity for COVID-19 prevention and control. Vaccine he
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89deb15cc6bfed10498d399fe7b0152c
https://hdl.handle.net/10023/24480
https://hdl.handle.net/10023/24480
Autor:
Osaretin E. Asowata, Jean Baptiste Nyandwi, Ajibola I Abioye, Hager Elnadi, Mfon Valencia Umoren, Hajj Daitoni, Folorunso Oludayo Fasina, Rasha A Mosbah, Gbolahan Idowu, Taofik A. Okuneye, Shameem Z. Jaumdally, Sifeuh Noussi Achille Fabrice, Ezekiel. F. Hallie, Bamu Fufor Damaris, Kennedy Makola Mbanzulu, Mena M. Abdalla, Haruna Isiyaku Umar, Ismail Olayinka Adesanya, Sodiq Olawale Tijani, Youssef Razouqi, Zuhal Mhgoob Ebrahim Mohammed, Kwame Sherrif Awiagah, Salim Parker, Joseph Eyedo, Maureen A. Obara, Gatera Fiston Kitewa, Aala MohmedOsman Maisara, AbdulAzeez A. Anjorin, Ismail Ayoade Odetokun
Publikováno v:
SSRN Electronic Journal.
Background: The economic and humanistic impact of the COVID-19 pandemic has been tremendous globally, including in Africa. No definitive treatment exists yet. The accelerated development and approval of COVID-19 vaccines, therefore, offers a unique o